The Treasury Department and IRS today released for publication in the Federal Register final regulations (T.D. 9772) that provide guidance to Blue Cross and Blue Shield organizations and other entities that qualify under section 833 on the computation of the medical loss ratio (MLR) and the consequences of not satisfying the MLR requirement.
Today’s final regulations [PDF 206 KB] amend the existing regulations under section 833, which were adopted in January 2014 (T.D. 9651), to reflect technical corrections made to the statute by the Appropriations Act on December 16, 2014.
The technical corrections provide that in calculating its MLR, an organization includes in the numerator both the cost of reimbursement for clinical services and amounts expended for activities that improve health care quality. The technical corrections further provide that the consequences for not satisfying the MLR requirement are that section 833(a)(2) and (3) do not apply to the organization, but the organization continues to be treated as a stock insurance company under section 833(a)(1).
© 2017 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.
The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.